018319304

AIM ImmunoTech

---

October 8, 2020

Trademark Summary

The trademark application AIM ImmunoTech was filed by AIM ImmunoTech Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 10, 2020, and it was registered by office on February 17, 2021 without any oppositions.

The application was filed in Swedish (English was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on July 1, 2021. Appointment and Replacement of representative of the trademark registration was recorded on August 31, 2021. Change of name and professional address of the trademark registration was recorded on July 14, 2022.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS
  2. Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS
  3. Intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns
  4. Interferons
  5. Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer
  6. Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS
  7. Intranasal solutions for use as a vaccine adjuvant.
• The mark was filed in class 42 with Pharmaceutical research and development and Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS..